<PAGE>
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[_] Preliminary Proxy Statement [_] Confidential, for Use of the
Commission Only (as permitted by
Rule 14a-6(e)(2))
[X] Definitive Proxy Statement
[_] Definitive Additional Materials
[_] Soliciting Material Pursuant to (S)240.14a-11(c) or (S)240.14a-12
THERMO INSTRUMENT SYSTEMS
------------------------------------------------
(Name of Registrant as Specified In Its Charter)
THERMO INSTRUMENT SYSTEMS
------------------------------------------------
(Name of Person(s) Filing Proxy Statement)
Payment of Filing Fee (check the appropriate box):
[X] No fee required
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
________________________________________________________________________
(2) Aggregate number of securities to which transaction applies:
________________________________________________________________________
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined):
________________________________________________________________________
(4) Proposed maximum aggregate value of transaction:
________________________________________________________________________
(5) Total fee paid:
________________________________________________________________________
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
________________________________________________________________________
(2) Form, Schedule or Registration Statement No.:
________________________________________________________________________
(3) Filing Party:
________________________________________________________________________
(4) Date Filed:
________________________________________________________________________
<PAGE>
THERMO INSTRUMENT SYSTEMS
860 West Airport Freeway, Suite 301
Hurst, TX 76054
April 23, 1998
Dear Stockholder:
The enclosed Notice calls the 1998 Annual Meeting of the Stockholders of
Thermo Instrument Systems Inc. We respectfully request that all Stockholders
attend this meeting, if possible.
Our Annual Report for the year ended January 3, 1998, is enclosed. We hope
you will read it carefully. Feel free to forward any questions you may have if
you are unable to be present at the meeting.
Enclosed with this letter is a proxy authorizing three officers of the
Corporation to vote your shares for you if you do not attend the meeting.
Whether or not you are able to attend the meeting, We urge you to complete your
proxy and return it to our transfer agent, American Stock Transfer & Trust
Company, in the enclosed addressed, postage-paid envelope, as a quorum of the
Stockholders must be present at the meeting, either in person or by proxy.
We would appreciate your immediate attention to the mailing of this proxy.
Yours very truly,
ARVIN H. SMITH
Chairman of the Board
EARL R. LEWIS
President and Chief Executive Officer
<PAGE>
THERMO INSTRUMENT SYSTEMS INC.
860 West Airport Freeway, Suite 301
Hurst, TX 76054
April 23, 1998
To the Holders of the Common Stock of
THERMO INSTRUMENT SYSTEMS INC.
NOTICE OF ANNUAL MEETING
The 1998 Annual Meeting of the Stockholders of Thermo Instrument Systems
Inc. (the "Corporation") will be held on Monday, June 1, 1998, at 9:00 a.m. at
The Hyatt Regency Scottsdale Resort at Gainey Ranch, 7500 East Doubletree Ranch
Road, Scottsdale, Arizona, 85258. The purpose of the meeting is to consider and
take action upon the following matters:
1. Election of six directors.
2. Such other business as may properly be brought before the meeting and any
adjournment thereof.
The transfer books of the Corporation will not be closed prior to the
meeting, but, pursuant to appropriate action by the board of directors, the
record date for the determination of the Stockholders entitled to receive notice
of and to vote at the meeting is April 3, 1998.
The By-laws require that the holders of a majority of the stock issued and
outstanding and entitled to vote be present or represented by proxy at the
meeting in order to constitute a quorum for the transaction of business. It is
important that your shares be represented at the meeting regardless of the
number of shares you may hold. Whether or not you are able to be present in
person, please sign and return promptly the enclosed proxy in the accompanying
envelope, which requires no postage if mailed in the United States.
This Notice, the proxy and proxy statement enclosed herewith are sent to
you by order of the board of directors.
SANDRA L. LAMBERT
Secretary
<PAGE>
PROXY STATEMENT
The enclosed proxy is solicited by the board of directors of Thermo
Instrument Systems Inc. (the "Corporation") for use at the 1998 Annual Meeting
of the Stockholders (the "Meeting") to be held on Monday, June 1, 1998, at 9:00
a.m. at The Hyatt Regency Scottsdale Resort at Gainey Ranch, Scottsdale,
Arizona, and any adjournment thereof. The mailing address of the executive
office of the Corporation is 860 West Airport Freeway, Suite 301, Hurst, TX
76054. This proxy statement and the enclosed proxy were first furnished to
Stockholders of the Corporation on or about April 29, 1998.
VOTING PROCEDURES
The board of directors intends to present to the Meeting the election of
six directors, constituting the entire board of directors.
The representation in person or by proxy of a majority of the outstanding
shares of the common stock of the Corporation, $.10 par value, ("Common Stock")
entitled to vote at the Meeting is necessary to provide a quorum for the
transaction of business at the Meeting. Shares can be voted only if the
Stockholder is present in person or is represented by returning a properly
signed proxy. Each Stockholder's vote is very important. Whether or not you plan
to attend the Meeting in person, please sign and promptly return the enclosed
proxy card, which requires no postage if mailed in the United States. All signed
and returned proxies will be counted towards establishing a quorum for the
Meeting, regardless of how the shares are voted.
Shares represented by proxy will be voted in accordance with your
instructions. You may specify your choice by marking the appropriate box on the
proxy card. If your proxy card is signed and returned without specifying
choices, your shares will be voted for the management nominees for directors and
as the individuals named as proxy holders on the proxy deem advisable on all
other matters as may properly come before the Meeting.
In order to be elected a director, a nominee must receive the affirmative
vote of a majority of the shares of Common Stock present and entitled to vote on
the election. Withholding authority to vote for a nominee for director will be
treated as shares present and entitled to vote and, for purposes of determining
the outcome of the vote, will have the same effect as a vote against the
nominee. With respect to the election of directors, broker "non-votes" will not
be treated as shares present and entitled to vote on a voting matter and will
have no effect on the outcome of the vote. A broker "non-vote" occurs when a
nominee holding shares for a beneficial holder does not have discretionary
voting power and does not receive voting instructions from the beneficial owner.
A Stockholder who returns a proxy may revoke it at any time before the
Stockholder's shares are voted at the Meeting by written notice to the Secretary
of the Corporation received prior to the Meeting, by executing and returning a
later dated proxy or by voting by ballot at the Meeting.
The outstanding stock of the Corporation entitled to vote (excluding shares
held in treasury by the Corporation) as of April 3, 1998 consisted of
122,116,565 shares of Common Stock. Only Stockholders of record at the close of
business on April 3, 1998 are entitled to vote at the Meeting. Each share is
entitled to one vote.
- PROPOSAL 1 -
ELECTION OF DIRECTORS
Six directors are to be elected at the Meeting, constituting the entire
board of directors, each to hold office until his successor is chosen and
qualified or until his earlier resignation, death or removal.
NOMINEES FOR DIRECTORS
Set forth below are the names of the persons nominated as directors, their
ages, their offices in the Corporation, if any, their principal occupation or
employment for the past five years, the length of their tenure as directors and
the names of other public companies in which such persons hold directorships.
Information regarding
1
<PAGE>
their beneficial ownership of the Corporation's Common Stock, and the common
stock of its subsidiaries and its parent company, Thermo Electron Corporation
("Thermo Electron"), a provider of diversified products and services for
biomedical, instrument and environmental markets, is reported under the caption
"Stock Ownership." All of the nominees are currently directors of the
Corporation.
<TABLE>
<S> <C>
- -----------------------------------------------------------------------------------------------------------------
FRANK BORMAN Col. Borman, 70, has been a director of the Corporation since 1986. Col.
Borman has been president and chief executive officer of Patlex Corporation,
a patent licensing company, and a trustee of the National Geographic Society,
for over five years. Col. Borman is also a director of American
Superconductor Corporation, Database Online Corporation and The Home Depot,
Inc.
- -----------------------------------------------------------------------------------------------------------------
GEORGE N. HATSOPOULOS Dr. Hatsopoulos, 71, has been a director of the Corporation since 1986. Dr.
Hatsopoulos has been the chairman and chief executive officer of Thermo
Electron since he founded the company in 1956 and president of Thermo
Electron from 1956 until January 1997. He was also chairman of the board of
the Corporation from 1986 to March 1997. Dr. Hatsopoulos is also a director
of Photoelectron Corporation, Thermedics Inc., Thermo Ecotek Corporation,
Thermo Electron, Thermo Fibertek Inc., Thermo Optek Corporation, ThermoQuest
Corporation and ThermoTrex Corporation. Dr. Hatsopoulos is the brother of
Mr. John N. Hatsopoulos, a director and the chief financial officer and a
senior vice president of the Corporation.
- -----------------------------------------------------------------------------------------------------------------
JOHN N. HATSOPOULOS Mr. Hatsopoulos, 63, has been a director of the Corporation since 1986 and
its chief financial officer since 1988. He was also vice president of the
Corporation from 1988 through December 1997 and has been its senior vice
president since December 1997. Mr. Hatsopoulos has been the president of
Thermo Electron since January 1997 and the chief financial officer of Thermo
Electron since 1988. He was also an executive vice president of Thermo
Electron from 1986 to January 1997. Mr. Hatsopoulos is also a director of
LOIS/USA Inc., ONIX Systems Inc., Thermedics Inc., Thermo Ecotek Corporation,
Thermo Electron, Thermo Fibertek Inc., Thermo Power Corporation and Thermo
TerraTech Inc. Mr. Hatsopoulos is the brother of Dr. George N. Hatsopoulos,
a director of the Corporation.
- -----------------------------------------------------------------------------------------------------------------
EARL R. LEWIS Mr. Lewis, 54, has been a director and the chief executive officer of the
Corporation since January 1998, and has been president of the Corporation
since March 1997. He was chief operating officer of the Corporation from
January 1996 to January 1998. Prior to that time, he was executive vice
president of the Corporation from January 1996 to March 1997, senior vice
president from January 1994 to January 1996, and vice president from March
1992 to January 1994. He has been a vice president of Thermo Electron since
September 1996. Prior to his appointment as the Corporation's chief
executive officer, Mr. Lewis was also chief executive officer of Thermo Optek
Corporation, a majority-owned subsidiary of the Corporation that manufactures
analytical instruments that measure energy and light for purposes of
materials analysis, characterization and preparation, from its inception in
August 1995 to January 1998 and was the president of its predecessor, Thermo
Jarrell Ash Corporation for more than five years prior to 1995. Mr. Lewis is
also director of Metrika Systems Corporation, ONIX Systems Inc., Thermo
BioAnalysis Corporation, Thermo Optek Corporation, ThermoQuest Corporation,
ThermoSpectra Corporation and Thermo Vision Corporation.
- -----------------------------------------------------------------------------------------------------------------
</TABLE>
2
<PAGE>
<TABLE>
<S> <C>
- -----------------------------------------------------------------------------------------------------------------
ARVIN H. SMITH Mr. Smith, 68, has been a director of the Corporation since 1986, and
chairman of the board since March 1997. He was also president and chief
executive officer of the Corporation from 1986 to March 1997 and January
1998, respectively. Mr. Smith is also chairman of the board of Thermo Power
Corporation, a majority-owned subsidiary of Thermo Electron that manufactures
traffic-control systems and industrial refrigeration equipment. He has been
an executive vice president of Thermo Electron since 1991 and was a senior
vice president of Thermo Electron from 1986 to 1991. Mr. Smith is also a
director of Metrika Systems Corporation, ONIX Systems Inc., Thermo
BioAnalysis Corporation, Thermo Optek Corporation, Thermo Power Corporation,
ThermoQuest Corporation, ThermoSpectra Corporation and Thermo Vision
Corporation.
- -----------------------------------------------------------------------------------------------------------------
POLYVIOS C. VINTIADIS Mr. Vintiadis, 62, has been a director of the Corporation since July 1993.
Mr. Vintiadis has been the chairman and chief executive officer of Towermarc
Corporation, a real estate development company, since 1984. Prior to joining
Towermarc, Mr. Vintiadis was a principal of Morgens, Waterfall & Vintiadis,
Inc., a financial services firm, with whom he remains associated. For more
than 20 years prior to that time, Mr. Vintiadis was employed by Arthur D.
Little & Company, Inc. Mr. Vintiadis is also a director of The Randers Group
Incorporated and Thermo TerraTech Inc.
- -----------------------------------------------------------------------------------------------------------------
</TABLE>
COMMITTEES OF THE BOARD OF DIRECTORS AND MEETINGS
The board of directors has established an audit committee and a human
resources committee. The audit committee consists solely of outside directors,
and its present members are Mr. Vintiadis (Chairman), and Col. Borman. The audit
committee reviews the scope of the audit with the Corporation's independent
public accountants and meets with them for the purpose of reviewing the results
of the audit subsequent to its completion. The human resources committee
consists solely of outside directors, and its present members are Col. Borman
(Chairman) and Mr. Vintiadis. The human resources committee reviews the
performance of senior members of management, approves executive compensation and
administers the Corporation's stock option and other stock-based compensation
plans. The Corporation does not have a nominating committee of the board of
directors. The board of directors met nine times, the audit committee met twice
and the human resources committee met three times during fiscal 1997. Each
director attended at least 75% of all meetings of the board of directors and
committees on which he served held during fiscal 1997.
COMPENSATION OF DIRECTORS
CASH COMPENSATION
Directors who are not employees of the Corporation, of Thermo Electron or
of any other companies affiliated with Thermo Electron (also referred to as
"outside directors") receive an annual retainer of $8,000 and a fee of $1,000
per day for attending regular meetings of the board of directors and $500 per
day for participating in meetings of the board of directors held by means of
conference telephone and for participating in certain meetings of committees of
the board of directors. Payment of directors' fees is made quarterly. Dr. G.
Hatsopoulos, Mr. J. Hatsopoulos, Mr. Lewis and Mr. Smith are all employees of
Thermo Electron or its subsidiaries and do not receive any cash compensation
from the Corporation for their services as directors. Directors are also
reimbursed for out-of-pocket expenses incurred in attending such meetings.
DEFERRED COMPENSATION PLAN
Under the Corporation's deferred compensation plan for directors (the
"Deferred Compensation Plan"), a director has the right to defer receipt of his
cash fees until he ceases to serve as a director, dies or retires from his
principal occupation. In the event of a change in control or proposed change in
control of the Corporation that is not approved by the board of directors,
deferred amounts become payable immediately. Either of the following is deemed
to be a change of control: (a) the acquisition, without the prior approval of
the board of directors, directly or
3
<PAGE>
indirectly, by any person of 50% or more of the outstanding Common Stock or 25%
or more of the outstanding common stock of Thermo Electron; or (b) the failure
of the persons serving on the board of directors immediately prior to any
contested election of directors or any exchange offer or tender offer for the
Common Stock or the common stock of Thermo Electron to constitute a majority of
the board of directors at any time within two years following any such event.
Amounts deferred pursuant to the Deferred Compensation Plan are valued at the
end of each quarter as units of the Corporation's Common Stock. When payable,
amounts deferred may be disbursed solely in shares of Common Stock accumulated
under the Deferred Compensation Plan. A total of 123,502 shares of Common Stock
has been reserved for issuance under the Deferred Compensation Plan. As of March
1, 1998, deferred units equal to 16,961.26 shares of Common Stock were
accumulated under the Deferred Compensation Plan.
DIRECTORS STOCK OPTION PLAN
The Corporation's directors stock option plan (the "Directors Plan"),
provides for the grant of stock options to purchase shares of common stock of
the Corporation and its majority-owned subsidiaries to outside directors as
additional compensation for their service as directors. Under the Directors
Plan, outside directors are automatically granted options to purchase 1,000
shares of the Common Stock annually. In addition, the Directors Plan provides
for the automatic grant every five years of options to purchase 1,500 shares of
the common stock of a majority-owned subsidiary of the Corporation that is "spun
out" to outside investors.
Pursuant to the Directors Plan, outside directors receive an annual grant
of options to purchase 1,000 shares of Common Stock at the close of business on
the date of each Annual Meeting of the Stockholders of the Corporation. Options
evidencing annual grants may be exercised at any time from and after the six-
month anniversary of the grant date of the option and prior to the expiration of
the option on the third anniversary of the grant date. Shares acquired upon
exercise of the options are subject to repurchase by the Corporation at the
exercise price if the recipient ceases to serve as a director of the Corporation
or any other Thermo Electron company prior to the first anniversary of the grant
date.
In addition, under the Directors Plan, outside directors are automatically
granted every five years options to purchase 1,500 shares of common stock of
each majority-owned subsidiary of the Corporation that is "spun out" to outside
investors. The grant occurs on the close of business on the date of the first
Annual Meeting of the Stockholders next following the subsidiary's spinout,
which is the first to occur of either an initial public offering of the
subsidiary's common stock or a sale of such stock to third parties in an arms-
length transaction, and also as of the close of business on the date of every
fifth Annual Meeting of the Stockholders of the Corporation that occurs
thereafter during the duration of the Plan. The options granted vest and become
exercisable on the fourth anniversary of the date of grant, unless prior to such
date the subsidiary's common stock is registered under Section 12 of the
Securities Exchange Act of 1934, as amended ("Section 12 Registration"). In the
event that the effective date of Section 12 Registration occurs before the
fourth anniversary of the grant date, the options will become immediately
exercisable and the shares acquired upon exercise will be subject to
restrictions on transfer and the right of the Corporation to repurchase such
shares at the exercise price in the event the director ceases to serve as a
director of the Corporation or any other Thermo Electron company. In the event
of Section 12 Registration, the restrictions and repurchase rights shall lapse
or be deemed to lapse at the rate of 25% per year, starting with the first
anniversary of the grant date. These options expire after five years. Under
this provision of the Directors Plan, each outside director was granted options
to purchase 1,500 shares of common stock of each of Metrika Systems Corporation
and Thermo Optek Corporation on June 2, 1997, the date of last year's Annual
Meeting of the Stockholders.
The exercise price for options granted under the Directors Plan is the
average of the closing prices of the common stock as reported on the American
Stock Exchange (or other principal market on which the common stock is then
traded) for the five trading days immediately preceding and including the date
of grant, or, if the shares are not then traded, at the last price per share
paid by third parties in an arms-length transaction prior to the option grant.
As of March 31, 1998, options to purchase 82,019 shares of Common Stock were
outstanding under the Directors Plan, options to purchase 3,512 shares had been
exercised, options to purchase 3,512 shares had lapsed, and options to purchase
90,250 shares of Common Stock were reserved for future grant.
4
<PAGE>
STOCK OWNERSHIP POLICIES FOR DIRECTORS
During 1996, the human resources committee of the board of directors (the
"Committee") established a stock holding policy for directors. The stock
holding policy requires each director to hold a minimum of 1,000 shares of
Common Stock. Directors are requested to achieve this ownership level by the
1998 Annual Meeting of Stockholders. The chief executive officer of the
Corporation is required to comply with a separate stock holding policy
established by the Committee in 1996, which is described in "Committee Report on
Executive Compensation - Stock Ownership Policies."
In addition, the Committee adopted a policy requiring directors to hold
shares of the Corporation's Common Stock equal to one-half of their net option
exercises over a period of five years. The net option exercise is determined by
calculating the number of shares acquired upon exercise of a stock option, after
deducting the number of shares that could have been traded to exercise the
option and the number of shares that could have been surrendered to satisfy tax
withholding obligations attributable to the exercise of the option. This policy
is also applicable to executive officers and is described in "Committee Report
on Executive Compensation - Stock Ownership Policies."
STOCK OWNERSHIP
The following table sets forth the beneficial ownership of Common Stock, as
well as the common stock of Thermo Electron and each majority-owned subsidiary
of the Corporation, as of March 1, 1998, with respect to (i) each director, (ii)
each executive officer named in the summary compensation table under the heading
"Executive Compensation" and (iii) all directors and current executive officers
as a group. In addition, the following table sets forth the beneficial ownership
of Common Stock as of March 1, 1998, with respect to each person who was known
by the Corporation to own beneficially more than 5% of the outstanding shares of
Common Stock.
While certain directors and executive officers of the Corporation are also
directors and executive officers of Thermo Electron or its subsidiaries other
than the Corporation, all such persons disclaim beneficial ownership of the
shares of Common Stock owned by Thermo Electron.
5
<PAGE>
<TABLE>
<CAPTION>
- -------------------------------------------------------------------------------------------------------------------
THERMO THERMO METRIKA ONIX THERMO
INSTRUMENT ELECTRON SYSTEMS SYSTEMS BIOANALYSIS
NAME (1) SYSTEMS INC. CORPORATION CORPORATION INC. CORPORATION
-------- ------------ ----------- ----------- ---- -----------
(2) (3) (4) (5) (6)
- -------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Thermo Electron Corporation (11) 110,742,312 -- -- -- --
Frank Borman 31,699 0 1,500 0 1,500
Richard W. K. Chapman 174,080 82,775 0 0 40,500
George N. Hatsopoulos 179,141 3,423,423 30,000 0 27,300
John N. Hatsopoulos 84,226 681,072 25,000 0 37,200
Denis A. Helm 197,644 163,353 26,000 0 15,000
Barry S. Howe 124,940 77,670 0 0 64,900
Earl R. Lewis 203,726 84,037 20,000 333 72,500
Arvin H. Smith 539,583 519,038 10,000 4,000 39,000
Polyvios C. Vintiadis 12,940 2,500 1,500 0 1,500
All directors and current executive
officers as a group (10 persons) 1,571,343 5,165,623 116,500 4,333 305,400
- -------------------------------------------------------------------------------------------------------------------
<CAPTION>
THERMO THERMO THERMO THERMO
OPTEK QUEST SPECTRA VISION
NAME (1) CORPORATION CORPORATION CORPORATION CORPORATION
-------- ----------- ----------- ----------- -----------
(7) (8) (9) (10)
- -------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Thermo Electron Corporation (11) -- -- -- --
Frank Borman 1,500 1,500 1,500 0
Richard W. K. Chapman 15,500 240,650 4,000 70
George N. Hatsopoulos 113,100 92,600 24,750 23,800
John N. Hatsopoulos 132,800 99,500 24,400 28,600
Denis A. Helm 15,200 10,000 4,000 0
Barry S. Howe 16,000 90,000 4,010 0
Earl R. Lewis 253,000 125,000 55,000 31,420
Arvin H. Smith 98,000 90,000 20,000 16,120
Polyvios C. Vintiadis 1,500 1,500 1,500 0
All directors and current executive
officers as a group (10 persons) 652,600 756,750 144,160 106,610
- -------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) Except as reflected in the footnotes to this table, shares of the common
stock beneficially owned consist of shares owned by the indicated person or
by that person for the benefit of minor children, and all share ownership
includes sole voting and investment power.
(2) The number of shares of the Common Stock shown in the table reflect a five-
for-four split of such stock distributed in October 1997 in the form of a
25% stock dividend. Shares of the Common Stock beneficially owned by Col.
Borman, Dr. Chapman, Dr. G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Helm, Mr.
Howe, Mr. Lewis, Mr. Smith, Mr. Vintiadis and all directors and current
executive officers as a group include 18,231, 140,624, 117,187, 70,312,
140,625, 111,327, 172,085, 292,968, 9,448 and 1,091,557 shares,
respectively, that such person or group has the right to acquire within 60
days of March 1, 1998, through the exercise of stock options. Shares
beneficially owned by Dr. G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Smith and
all directors and current executive officers as a group include 598, 661,
663 and 2,417 full shares, respectively, allocated through March 1, 1998,
to their respective accounts maintained pursuant to Thermo Electron's
6
<PAGE>
employee stock ownership plan, of which the trustees, who have investment
power over its assets, are executive officers of Thermo Electron (the
"ESOP"). Shares beneficially owned by Col. Borman, Mr. Vintiadis and all
directors and current executive officers as a group include 13,468, 3,492
and 16,960 full shares, respectively, allocated through March 1, 1998, to
their respective accounts maintained under the Corporation's Deferred
Compensation Plan for directors. Shares beneficially owned by Dr. G.
Hatsopoulos include 26,710 shares held by his spouse and 63 shares
allocated through March 1, 1998, to his spouse's account maintained
pursuant to the ESOP. Shares beneficially owned by Mr. Helm include a
total of 5,264 shares held in custodial accounts for the benefit of his
minor children. Shares beneficially owned by Mr. Howe include 2,460 shares
held in custodial accounts for the benefit of four minor children. Shares
beneficially owned by Mr. Lewis include 2,987 shares held by his spouse.
No director or executive officer beneficially owned more than 1% of the
Common Stock outstanding as of March 1, 1998; all directors and current
executive officers as a group beneficially owned 1.3% of the Common Stock
outstanding as of such date.
(3) Shares of the common stock of Thermo Electron beneficially owned by Dr.
Chapman, Dr. G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Helm, Mr. Howe, Mr.
Lewis, Mr. Smith and all directors and current executive officers as a
group include 80,584, 1,649,500, 615,435, 105,322, 68,687, 84,037, 228,411
and 2,972,013 shares, respectively, that such person or group has the right
to acquire within 60 days of March 1, 1998, through the exercise of stock
options. Shares beneficially owned by Dr. G. Hatsopoulos, Mr. J.
Hatsopoulos, Mr. Smith and all directors and executive officers as a group
include 2,266, 2,036, 1,717 and 7,445 full shares, respectively, allocated
through March 1, 1998, to their respective accounts maintained pursuant to
the ESOP. Shares beneficially owned by Dr. G. Hatsopoulos include 89,601
shares held by his spouse, 168,750 shares held by a QTIP trust of which his
spouse is a trustee, 39,937 shares held by a family trust of which his
spouse is a trustee, 4,000 shares held by an additional family trust of
which Dr. Elias P. Gyftopoulos is a trustee and 153 full shares allocated
through March 1, 1998, to his spouse's account maintained pursuant to the
ESOP. Shares beneficially owned by Dr. G. Hatsopoulos also include 50,000
shares that a family trust, of which Dr. G. Hatsopoulos' spouse is the
trustee, has the right to acquire within 60 days of March 1, 1998, through
the exercise of stock options. Shares beneficially owned by Mr. Howe
include 200 shares held in custodial accounts for the benefit of his minor
children. Except for Dr. G. Hatsopoulos, who beneficially owned 2.1% of
the Thermo Electron common stock outstanding as of March 1, 1998, no
director or executive officer beneficially owned more than 1% of such
common stock outstanding as of such date; all directors and current
executive officers as a group beneficially owned 3.2% of the Thermo
Electron common stock outstanding as of March 1, 1998.
(4) Shares of the common stock of Metrika Systems Corporation a majority-owned
subsidiary of the Corporation ("Metrika Systems"), have been adjusted to
reflect a one-for-two reverse stock split effected in May 1997. Shares of
the common stock of Metrika Systems beneficially owned by Col. Borman, Dr.
G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Helm, Mr. Lewis, Mr. Smith, Mr.
Vintiadis and all directors and executive officers as a group include
1,500, 30,000, 10,000, 25,000, 20,000, 10,000, 1,500 and 100,500 shares,
respectively, that such person or group has the right to acquire within 60
days of March 1, 1998, through the exercise of stock options. No director
or executive officer beneficially owned more than 1% of the common stock of
Metrika Systems outstanding as of March 1, 1998; all directors and
executive officers as a group beneficially owned 1.4% of such common stock
outstanding as of such date.
(5) Shares of the common stock of ONIX Systems Inc., a majority-owned
subsidiary of the Corporation ("ONIX Systems"), beneficially owned by Mr.
Lewis include 333 shares held by his son. Shares beneficially owned by Mr.
Smith include 4,000 shares held by his spouse. The directors and executive
officers of the Corporation did not individually or as a group beneficially
own more than 1% of the common stock of ONIX Systems as of March 1, 1998.
(6) Shares of the common stock of Thermo BioAnalysis Corporation, a majority-
owned subsidiary of the Corporation ("Thermo BioAnalysis"), beneficially
owned by Col. Borman, Dr. Chapman, Dr. G. Hatsopoulos, Mr. J. Hatsopoulos,
Mr. Helm, Mr. Howe, Mr. Lewis, Mr. Smith, Mr. Vintiadis and all directors
and current executive officers as a group include 1,500, 30,000, 17,300,
17,200, 15,000, 50,000, 50,000, 20,000, 1,500 and 205,500 shares,
respectively, that such person or group has the right to acquire within 60
days of March 1, 1998, through the exercise of stock options. Shares
beneficially owned by Mr.
7
<PAGE>
Howe include 600 shares held by Mr. Howe in custodial accounts for the
benefit of his minor children. Shares beneficially owned by Mr. Lewis
include 1,000 shares held by his spouse. No director or executive officer
beneficially owned more than 1% of the common stock of Thermo BioAnalysis
outstanding as of March 1, 1998; all directors and current executive
officers as a group beneficially owned 2.8% of such common stock
outstanding as of such date.
(7) Shares of the common stock of Thermo Optek Corporation, a majority-owned
subsidiary of the Corporation ("Thermo Optek"), beneficially owned by Col.
Borman, Dr. Chapman, Dr. G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Helm, Mr.
Howe, Mr. Lewis, Mr. Smith, Mr. Vintiadis and all directors and current
executive officers as a group include 1,500, 15,000, 93,100, 92,800,
15,000, 15,000, 225,000, 90,000, 1,500 and 554,900 shares, respectively,
that such person or group has the right to acquire within 60 days of March
1, 1998, through the exercise of stock options. Shares beneficially owned
by Mr. Howe include 1,000 shares held by Mr. Howe in custodial accounts for
the benefit of his minor children. Shares beneficially owned by Mr. Lewis
include 2,500 shares held by his spouse and 1,000 shares held by his son.
No director or executive officer beneficially owned more than 1% of the
common stock of Thermo Optek outstanding as of March 1, 1998; and directors
and current executive officers as a group beneficially owned 1.3% of such
common stock outstanding as of such date.
(8) Shares of the common stock of ThermoQuest Corporation, a majority-owned
subsidiary of the Corporation ("ThermoQuest"), beneficially owned by Col.
Borman, Dr. Chapman, Dr. G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Helm, Mr.
Howe, Mr. Lewis, Mr. Smith, Mr. Vintiadis and all directors and current
executive officers as a group include 1,500, 225,000, 92,600, 92,400,
10,000, 90,000, 125,000, 90,000, 1,500 and 734,000 shares, respectively,
that such person or group has the right to acquire within 60 days of March
1, 1998, through the exercise of stock options. No director or executive
officer beneficially owned more than 1% of the common stock of ThermoQuest
outstanding as of March 1, 1998; all directors and current executive
officers as a group beneficially owned 1.5% of such common stock
outstanding as of such date.
(9) Shares of the common stock of ThermoSpectra Corporation, a majority-owned
subsidiary of the Corporation ("ThermoSpectra"), beneficially owned by Col.
Borman, Dr. Chapman, Dr. G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Helm, Mr.
Howe, Mr. Lewis, Mr. Smith, Mr. Vintiadis and all directors and current
executive officers as a group include 1,500, 4,000, 24,750, 24,400, 4,000,
4,000, 50,000, 20,000, 1,500 and 139,150 shares, respectively, that such
person or group has the right to acquire within 60 days of March 1, 1998,
through the exercise of stock options. No director or executive officer
beneficially owned more than 1% of the common stock of ThermoSpectra
outstanding as of March 1, 1998; all directors and current executive
officers as a group beneficially owned less than 1% of such common stock
outstanding as of such date.
(10) Shares of the common stock of Thermo Vision Corporation, a majority-owned
subsidiary of the Corporation ("Thermo Vision"), beneficially owned by Dr.
G. Hatsopoulos, Mr. J. Hatsopoulos, Mr. Lewis, Mr. Smith and all directors
and current executive officers as a group include 15,000, 15,000, 25,000,
15,000 and 72,000 shares, respectively, that such person or group has the
right to acquire within 60 days of March 1, 1998, through the exercise of
stock options. Shares beneficially owned by Mr. J. Hatsopoulos include
3,000 shares held by his spouse. Shares beneficially owned by Mr. Lewis
include 450 shares held by his spouse and 490 shares held by his son. No
director or executive officer beneficially owned more than 1% of the common
stock of Thermo Vision outstanding as of March 1, 1998; all directors and
current executive officers as a group beneficially owned 1.3% of such
common stock outstanding as of such date.
(11) Includes 10,334,620 shares of Common Stock that Thermo Electron has the
right to acquire within 60 days of March 1, 1998, through the conversion of
certain convertible notes of the Corporation held by Thermo Electron.
Thermo Electron beneficially owned approximately 83.6% of the Common Stock
outstanding as of March 1, 1998. Thermo Electron's address is 81 Wyman
Street, Waltham, Massachusetts 02254-9046.
8
<PAGE>
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934 requires the
Corporation's directors and executive officers, and beneficial owners of more
than 10% of the Common Stock, such as Thermo Electron, to file with the
Securities and Exchange Commission initial reports of ownership and periodic
reports of changes in ownership of the Corporation's securities. Based upon a
review of such filings, all Section 16(a) filing requirements applicable to such
persons were complied with during 1997, except in the following instance.
Thermo Electron filed six Forms 4 late, reporting a total of 21 transactions,
including 11 open market purchases of shares of Common Stock and 10 transactions
associated with the grant and exercise of options to purchase Common Stock
granted to employees under its stock option program.
EXECUTIVE COMPENSATION
NOTE: The shares reported below, in all cases, have been adjusted as applicable
to reflect a (i) five-for-four stock split of the Common Stock distributed in
October 1997 in the form of a 25% stock dividend and (ii) a one-for-two reverse
stock split of the common stock of Metrika Systems Corporation effected in May
1997.
SUMMARY COMPENSATION TABLE
The following table summarizes compensation for services to the Corporation
in all capacities awarded to, earned by or paid to the Corporation's chief
executive officer and its four other most highly compensated executive officers
for the last three fiscal years.
The Corporation is required to appoint certain executive officers and full-
time employees of Thermo Electron as executive officers of the Corporation, in
accordance with the Thermo Electron Corporate Charter. The compensation for
these executive officers is determined and paid entirely by Thermo Electron. The
time and effort devoted by these individuals to the Corporation's affairs is
provided to the Corporation under the Corporate Services Agreement between the
Corporation and Thermo Electron. Accordingly, the compensation for these
individuals is not reported in the following table.
9
<PAGE>
<TABLE>
<CAPTION>
SUMMARY COMPENSATION TABLE
- ------------------------------------------------------------------------------------------------------------------------------------
LONG TERM
COMPENSATION
------------
ANNUAL COMPENSATION SECURITIES UNDERLYING
NAME AND FISCAL ------------------- OPTIONS (NO. OF SHARES ALL OTHER
PRINCIPAL POSITION YEAR SALARY BONUS AND COMPANY)(1) COMPENSATION(2)
------------------ ---- ------ ----- --------------- ---------------
<S> <C> <C> <C> <C> <C>
Arvin H. Smith (3) 1997 $142,500 $150,000 10,000 (MKA) $7,125
Chairman and 15,000 (VIZ)
Chief Executive Officer 1996 $135,000 $130,000 20,000 (TBA) $6,750
90,000 (TOC)
90,000 (TMQ)
1995 $131,000 $128,100 -- $6,750
- ------------------------------------------------------------------------------------------------------------------------------------
Earl R. Lewis (4) 1997 $198,000 $225,000 62,500 (THI) $16,710 (5)
President and 20,000 (MKA)
Chief Operating Officer 75,000 (TMQ)
25,000 (VIZ)
1996 $180,000 $160,000 42,500 (TBA) $11,550 (5)
2,000 (TFG)
2,000 (TLT)
225,000 (TOC)
2,000 (TSR)
50,000 (TMQ)
40,000 (TXM)
1995 $145,000 $90,000 150 (TMO) $6,750
7,500 (TBA)
5,000 (TLZ)
- ------------------------------------------------------------------------------------------------------------------------------------
Denis A. Helm (6) 1997 $155,000 $92,000 3,700 (TMO) $7,125
Senior Vice President 25,000 (MKA)
1996 $150,000 $86,400 3,900 (TMO) $6,681
15,000 (TBA)
15,000 (TOC)
10,000 (TMQ)
1995 $142,000 $81,000 4,350 (TMO) $6,750
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
10
<PAGE>
<TABLE>
<CAPTION>
SUMMARY COMPENSATION TABLE
- ------------------------------------------------------------------------------------------------------------------------------------
LONG TERM
COMPENSATION
------------
ANNUAL COMPENSATION SECURITIES UNDERLYING
NAME AND FISCAL ------------------- OPTIONS (NO. OF SHARES ALL OTHER
PRINCIPAL POSITION YEAR SALARY BONUS AND COMPANY)(1) COMPENSATION(2)
------------------ ---- ------ ----- --------------- ---------------
<S> <C> <C> <C> <C> <C>
Richard W. K. Chapman (6) 1997 $180,000 $153,000 300 (TMO) $22,309 (7)
Vice President 1996 $170,000 $125,000 150 (TMO) $7,021 (7)
30,000 (TBA)
2,000 (TFG)
2,000 (TLT)
15,000 (TOC)
225,000 (TMQ)
2,000 (TSR)
4,000 (TXM)
1995 $159,500 $95,000 150 (TMO) $6,749
5,000 (TLZ)
- ------------------------------------------------------------------------------------------------------------------------------------
Barry S. Howe (6) 1997 $150,000 $110,000 1,100 (TMO) $14,923 (8)
Vice President 1996 $145,000 $70,000 1,500 (TMO) $8,076 (7)
50,000 (TBA)
2,000 (TFG)
2,000 (TLT)
15,000 (TOC)
90,000 (TMQ)
2,000 (TSR)
4,000 (TXM)
1995 $134,000 $65,000 1,650 (TMO) $7,517
5,000 (TLZ)
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) In addition to grants of options to purchase Common Stock of the
Corporation (designated in the table as THI), executive officers of the
Corporation have been granted options to purchase common stock of Thermo
Electron and certain of its other subsidiaries as part of Thermo Electron's
stock option program. Options have been granted during the last three
fiscal years to the chief executive officer and the other named executive
officers in the following Thermo Electron companies: Thermo Electron
Corporation (designated in the table as TMO), Metrika Systems Corporation
(designated in the table as MKA), Thermo BioAnalysis (designated in the
table as TBA) Thermo Fibergen Inc. (designated in the table as TFG),
ThermoLase Corporation (designated in the table as TLZ), ThermoLyte
Corporation (designated in the table as TLT), Thermo Optek Corporation
(designated in the table as TOC), ThermoQuest Corporation (designated in
the table as TMQ), Thermo Sentron Inc. (designated in the table as TSR),
Thermo Vision Corporation (designated in the table as VIZ) and Trex Medical
Corporation (designated in the table as TXM).
(2) Represents the amount of matching contributions made on behalf of the
executive officers participating in the Thermo Electron 401(k) plan or, in
the case of Dr. Chapman, the 401(k) plan maintained by Finnigan
Corporation, a subsidiary of the Corporation.
(3) Mr. Smith served as chief executive officer of the Corporation for the
three years reported in the table until January 4, 1998, when he was named
chairman of the board. He served as president until March 4, 1997. Mr.
Smith has been both executive vice president of Thermo Electron, and
president and/or chief executive
11
<PAGE>
officer of the Corporation, for the last three fiscal years. A portion of
Mr. Smith's annual cash compensation (salary and bonus) has been paid by
Thermo Electron in each of the last three fiscal years as compensation for
the services provided to Thermo Electron based on the time he devoted to
his responsibilities as an executive vice president of Thermo Electron. The
annual cash compensation (salary and bonus) reported in the table for Mr.
Smith represents the amount paid by the Corporation and its subsidiaries
solely for Mr. Smith's services as chief executive officer of the
Corporation. For each of 1997, 1996 and 1995, 50% of Mr. Smith's annual
compensation (salary and bonus) was allocated to the Corporation for his
service as the Corporation's chief executive officer. In addition, Mr.
Smith has been granted options to purchase common stock of Thermo Electron
and certain of its subsidiaries other than the Corporation and its majority
-owned subsidiaries, from time to time by Thermo Electron or such other
subsidiaries. These options are not reported in this table as they were
granted as compensation for service to other Thermo Electron companies in
capacities other than in his capacity as the chief executive officer of the
Corporation.
(4) Mr. Lewis became president of the Corporation on March 4, 1997, and chief
executive officer of the Corporation on January 4, 1998. From January 1996
to March 1997 and January 1998, respectively, he was executive vice
president and chief operating officer of the Corporation. Prior to January
1996, he served as a senior vice president of the Corporation. In
September 1996, Mr. Lewis became a vice president of Thermo Electron. A
portion of Mr. Lewis's annual cash compensation (salary and bonus) has been
paid by Thermo Electron in fiscal 1997 as compensation for the services
provided to Thermo Electron based on the time he devoted to his
responsibilities as a vice president of Thermo Electron. The annual cash
compensation (salary and bonus) reported in the table for Mr. Lewis
represents the amount paid by the Corporation and its subsidiaries for Mr.
Lewis's services as president and chief executive officer of the
Corporation and as president (until April 4, 1997) and chief executive
officer (throughout 1997) of Thermo Optek. For 1997, 80% of Mr. Lewis's
annual cash compensation (salary and bonus) was paid by the Corporation for
his service as the Corporation's president and chief executive officer, and
an additional 10% of Mr. Lewis's annual cash compensation was paid by
Thermo Optek for his services as its president and chief executive officer.
In addition, Mr. Lewis has been granted options to purchase common stock of
Thermo Electron and certain of its subsidiaries other than the Corporation
and its majority-owned subsidiaries, from time to time by Thermo Electron
or such other subsidiaries. These options are not reported in this table
as they were granted as compensation for service to other Thermo Electron
companies in capacities other than in his capacity as the president and
chief executive officer of the Corporation.
(5) In addition to the matching contribution referred to in footnote (2), such
amount includes $9,585 and $4,800, respectively, which represents the
amount of compensation in fiscal 1997 and 1996, respectively, attributable
to an interest-free loan provided to Mr. Lewis pursuant to the stock
holding assistance plan of Thermo Optek. See "Relationship with Affiliates
- Stock Holding Assistance Plans."
(6) Ninety percent of Mr. Helm's cash compensation (salary and bonus) was paid
by the Corporation and 10% of his cash compensation was paid by Metrika
Systems Corporation, a majority-owned subsidiary of the Corporation. One
hundred percent of Mr. Chapman's cash compensation was paid by ThermoQuest
Corporation, the Corporation's majority-owned subsidiary that he serves as
president and chief executive officer. One hundred percent of Mr. Howe's
compensation was paid by Thermo BioAnalysis Corporation, the Corporation's
majority-owned subsidiary that he served as president and chief executive
officer during 1997.
(7) In addition to the matching contribution referred to in footnote (2), such
amount includes $18,154 and $4,334, respectively, which represents the
amount of compensation in fiscal 1997 and 1996, respectively, attributable
to interest-free loans provided to Dr. Chapman pursuant to the stock
holding assistance plans of Thermo BioAnalysis and ThermoQuest. See
"Relationship with Affiliates - Stock Holding Assistance Plans."
(8) In addition to the matching contribution referred to in footnote (2), such
amount includes $8,173 and $1,444, respectively, which represents the
amount of compensation in fiscal 1997 and 1996, respectively, attributable
to an interest-free loan provided to Mr. Howe pursuant to the stock holding
assistance plan of Thermo BioAnalysis. See "Relationship with Affiliates -
Stock Holding Assistance Plans."
12
<PAGE>
STOCK OPTIONS GRANTED DURING FISCAL 1997
The following table sets forth information concerning individual grants of
stock options made during fiscal 1997 to the Corporation's chief executive
officer and the other named executive officers. It has not been the
Corporation's policy in the past to grant stock appreciation rights, and no such
rights were granted during fiscal 1997.
<TABLE>
<CAPTION>
OPTION GRANTS IN FISCAL 1997
- ------------------------------------------------------------------------------------------------------------------------------------
POTENTIAL REALIZABLE
PERCENT OF VALUE AT ASSUMED
TOTAL OPTIONS ANNUAL RATES OF STOCK
NUMBER OF SECURITIES GRANTED TO EXERCISE PRICE APPRECIATION FOR
UNDERLYING OPTIONS EMPLOYEES IN PRICE PER EXPIRATION OPTION TERM(2)
NAME GRANTED (1) FISCAL YEAR SHARE DATE 5% 10%
---- ---------- ------------ ----- ---- ------------ ----------
<S> <C> <C> <C> <C> <C> <C>
Arvin H. Smith (3) 10,000 (MKA) 3.5(5) $15.00 5/23/09 $119,400 $320,800
15,000 (VIZ) 5.2(5) $7.50 12/5/04 $45,750 $106,800
- ------------------------------------------------------------------------------------------------------------------------
Earl R. Lewis (4) 62,500 (THI) 10.20% $26.29 7/11/09 $1,307,500 $3,513,750
20,000 (MKA) 7.0(5) $15.00 5/23/09 $238,800 $641,600
75,000 (TMQ) 8.4(5) $15.74 7/14/09 $939,750 $2,524,500
25,000 (VIZ) 8.7(5) $7.50 12/5/04 $76,250 $178,000
- ------------------------------------------------------------------------------------------------------------------------
Denis A. Helm 3,700 (TMO) 0.3(5) $34.20 6/3/00 $19,943 $41,884
25,000 (MKA) 8.8(5) $15.00 5/23/09 $298,500 $802,000
- ------------------------------------------------------------------------------------------------------------------------
Richard W. K. Chapman 300 (TMO) 0.0(5) $34.20 6/3/00 $1,617 $3,396
- ----------------------------------------------------------------------------------------------------------------------------------
Barry S. Howe 1,100 (TMO) 0.0(5) $34.20 6/3/00 $5,929 $12,452
- ------------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) All of the options granted during the fiscal year are immediately
exercisable as of the end of the fiscal year. In all cases, the shares
acquired upon exercise are subject to repurchase by the granting
corporation at the exercise price if the optionee ceases to be employed by
such corporation or any other Thermo Electron company. The granting
corporation may exercise its repurchase rights within six months after the
termination of the optionee's employment. The repurchase rights generally
lapse ratably over a five- to ten-year period, depending on the option
term, which may vary from seven to twelve years, provided that the optionee
continues to be employed by the Corporation or another Thermo Electron
company. Certain options have three-year terms and the repurchase rights
lapse in their entirety on the second anniversary of the grant date. The
granting corporation may permit the holders of options to exercise options
and to satisfy tax withholding obligations by surrendering shares equal in
fair market value to the exercise price or withholding obligation.
(2) The amounts shown on this table represent hypothetical gains that could be
achieved for the respective options if exercised at the end of the option
term. These gains are based on assumed rates of stock appreciation of 5%
and 10% compounded annually from the date the respective options were
granted to their expiration date. The gains shown are net of the option
exercise price, but do not include deductions for taxes or other expenses
associated with the exercise. Actual gains, if any, on stock option
exercises will depend on the future performance of the common stock of the
granting corporation, the optionee's continued employment through the
option period and the date on which the options are exercised.
(3) Mr. Smith has served as an executive officer of Thermo Electron since 1986
and has been granted options to purchase common stock of Thermo Electron
and certain of its subsidiaries other than the Corporation and its
majority-owned subsidiaries. These options are not reported in the table as
they were granted as compensation for service to other Thermo Electron
companies in capacities other than in his capacity as chief executive
officer of the Corporation.
13
<PAGE>
(4) Mr. Lewis has served as a vice president of Thermo Electron since September
1996 and from time to time thereafter has been granted options to purchase
common stock of Thermo Electron. These options are not reported in the
table as they were granted as compensation for service to Thermo Electron
in a capacity other than in his capacity as an executive officer of the
Corporation.
(5) These options were granted under stock option plans maintained by Thermo
Electron companies other than the Corporation and accordingly are reported
as a percentage of total options granted to employees of Thermo Electron
and its subsidiaries.
STOCK OPTIONS EXERCISED DURING FISCAL 1997 AND FISCAL YEAR-END OPTION
VALUES
The following table reports certain information regarding stock option
exercises during fiscal 1997 and outstanding stock options held at the end of
fiscal 1997 by the Corporation's chief executive officer and the other named
executive officers. No stock appreciation rights were exercised or were
outstanding during fiscal 1997.
14
<PAGE>
<TABLE>
<CAPTION>
AGGREGATED OPTION EXERCISES IN FISCAL 1997 AND FISCAL 1997 YEAR-END OPTION VALUES
- ------------------------------------------------------------------------------------------------------------------------------------
NUMBER OF
UNEXERCISED
SHARES OPTIONS AT FISCAL VALUE OF
ACQUIRED VALUE YEAR-END UNEXERCISED
ON REALIZED (EXERCISABLE/ IN-THE-MONEY
NAME COMPANY EXERCISE (1) UNEXERCISABLE)(2) OPTIONS
---- ------- --------- --- ----------------- --------
<S> <C> <C> <C> <C> <C>
Arvin H. Smith (3) Thermo Instrument Systems -- -- 292,968 /0 $6,052,719 /--
Metrika Systems -- -- 10,000 /0 $3,750 /--
Thermo BioAnalysis -- -- 20,000 /0 $190,000 /--
Thermo Optek -- -- 90,000 /0 $430,200 /--
ThermoQuest -- -- 90,000 /0 $450,000 /--
ThermoSpectra -- -- 20,000 /0 $1,260 /--
Thermo Vision -- -- 15,000 /0 $8,445 /--
- ------------------------------------------------------------------------------------------------------------------------------------
Earl R. Lewis (4) Thermo Instrument Systems -- -- 203,125 /0 (5) $3,387,188 /--
Thermo Electron 27,563 $612,254 99,374 /0 $2,471,582 /--
Metrika Systems -- -- 20,000 /0 $7,500 /--
Thermo BioAnalysis -- -- 50,000 /0 $390,000 /--
Thermo Fibergen -- -- 2,000 /0 $0 /--
Thermo Fibertek 1,350 $9,956 0 /0 -- /--
ThermoLase -- -- 5,000 /0 $0 /--
ThermoLyte -- -- 0 /2,000 -- /$0(6)
Thermo Optek -- -- 225,000 /0 $1,075,500 /--
ThermoQuest -- -- 125,000 /0 $419,500 /--
Thermo Sentron -- -- 2,000 /0 $0 /--
ThermoSpectra -- -- 50,000 /0 $3,150 /--
Thermo Vision -- -- 25,000 /0 $14,075 /--
Trex Medical -- -- 40,000 /0 $125,000 /--
- ------------------------------------------------------------------------------------------------------------------------------------
Denis A. Helm Thermo Instrument Systems -- -- 140,625 /0 $2,905,313 /--
Thermo Electron -- -- 110,047 /0(7) $2,592,809 /--
Metrika Systems -- -- 25,000 /0 $9,375 /--
Thermo BioAnalysis -- -- 15,000 /0 $142,500 /--
Thermo Ecotek 6,000 $65,250 0 /0 -- /--
Thermo Fibertek -- -- 6,750 /0 $62,019 /--
Thermo Optek -- -- 15,000 /0 $71,700 /--
ThermoQuest -- -- 10,000 /0 $50,000 /--
ThermoSpectra -- -- 4,000 /0 $252 /--
ThermoTrex -- -- 2,100 /0 $38,955 /--
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
15
<PAGE>
<TABLE>
<CAPTION>
AGGREGATED OPTION EXERCISES IN FISCAL 1997 AND FISCAL 1997 YEAR-END OPTION VALUES
- ------------------------------------------------------------------------------------------------------------------------------------
NUMBER OF
UNEXERCISED
SHARES OPTIONS AT FISCAL VALUE OF
ACQUIRED VALUE YEAR-END UNEXERCISED
ON REALIZED (EXERCISABLE/ IN-THE-MONEY
NAME COMPANY EXERCISE (1) UNEXERCISABLE)(2) OPTIONS
---- ------- --------- --- ----------------- ---------------
<S> <C> <C> <C> <C> <C>
Richard W. K. Chapman Thermo Instrument Systems -- -- 151,607 /0 $3,264,160 /--
Thermo Electron -- -- 80,584 /0(7) $1,995,039 /--
Thermo BioAnalysis -- -- 30,000 /0 $285,000 /--
Thermo Fibergen -- -- 2,000 /0 $0 /--
Thermo Fibertek -- -- 6,750 /0 $62,019 /--
ThermoLase -- -- 5,000 /0 $0 /--
ThermoLyte -- -- 0 /2,000 -- /$0 (6)
Thermo Optek -- -- 15,000 /0 $71,700 /--
ThermoQuest -- -- 225,000 /0 $1,125,000 /--
Thermo Sentron -- -- 2,000 /0 $0 /--
ThermoSpectra -- -- 4,000 /0 $252 /--
ThermoTrex -- -- 270 /0 5,009 /--
Trex Medical -- -- 4,000 /0 $12,500 /--
- ------------------------------------------------------------------------------------------------------------------------------------
Barry S. Howe Thermo Instrument Systems -- -- 111,327 /0 $2,418,661 /--
Thermo Electron 5,700 $154,655 68,687 /0(7) $1,667,339 /--
Thermedics -- -- 4,000 /0 $1,852 /--
Thermo BioAnalysis -- -- 50,000 /0 $475,000 /--
Thermo Ecotek -- -- 6,000 /0 $75,750 /--
Thermo Fibergen -- -- 2,000 /0 $0 /--
Thermo Fibertek -- -- 15,750 /0 $115,101 /--
ThermoLase -- -- 5,000 /0 $0 /--
ThermoLyte -- -- 0 /2,000 -- /$0 (6)
Thermo Optek -- -- 15,000 /0 $71,700 /--
Thermo Power -- -- 4,000 /0 $0 /--
ThermoQuest -- -- 90,000 /0 $450,000 /--
Thermo Sentron -- -- 2,000 /0 $0 /--
ThermoSpectra -- -- 4,000 /0 $252 /--
Thermo TerraTech -- -- 4,000 /0 $0 /--
ThermoTrex -- -- 4,000 /0 $29,200 /--
Trex Medical -- -- 4,000 /0 $12,500 /--
- --------------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) Amounts shown in this column do not necessarily represent actual value
realized from the sale of the shares acquired upon exercise of the option
because in many cases the shares are not sold on exercise but continue to
be held by the executive officer exercising the option. The amounts shown
represent the difference between the option exercise price and the market
price on the date of exercise, which is the amount that would have been
realized if the shares had been sold immediately upon exercise.
(2) All of the options reported outstanding at the end of the fiscal year were
immediately exercisable as of fiscal year-end, except options to purchase
the common stock of ThermoLyte Corporation, which are not exercisable until
the earlier of (i) 90 days after the effective date of the registration of
that company's common stock under Section 12 of the Exchange Act and (ii)
nine years after the grant date. In all cases, the shares acquired upon
exercise of the options reported in the table are subject to repurchase by
the granting corporation at the exercise price if the optionee ceases to be
employed by such corporation or any other Thermo Electron company. The
granting corporation may exercise its repurchase rights within six months
after the termination of the optionee's employment. For publicly traded
companies, the repurchase rights generally lapse ratably over a five- to
ten-year period, depending on the option term, which may vary from seven to
twelve years, provided that the optionee continues to be employed by the
Corporation or another Thermo Electron company. Certain options have three-
year terms and the repurchase rights lapse in their entirety on the second
anniversary of the grant date. For companies whose shares are not publicly
traded, the repurchase
16
<PAGE>
rights lapse in their entirety on the ninth anniversary of the grant date.
The granting corporation may permit the holders of options to exercise
options and to satisfy tax withholding obligations by surrendering shares
equal in fair market value to the exercise price or withholding obligation.
(3) As an executive officer of Thermo Electron, Mr. Smith also holds other
unexercised options to purchase common stock of Thermo Electron and certain
of its subsidiaries other than the Corporation and its majority-owned
subsidiaries. These options are not reported here as they were granted as
compensation for service to other Thermo Electron companies in capacities
other than his capacity as the chief executive officer of the Corporation.
(4) Mr. Lewis has served as a vice president of Thermo Electron since September
1996 and from time to time thereafter has been granted options to purchase
common stock of Thermo Electron. These options are not reported in the
table as they were granted as compensation for service to Thermo Electron
in a capacity other than his capacity as an executive officer of the
Corporation.
(5) Options to purchase 62,500 shares of the Common Stock of the Corporation
granted to Mr. Lewis are subject to the same terms as described in footnote
(2), except that the repurchase rights are deemed to lapse 20% per year
commencing on the sixth anniversary of the grant date.
(6) No public market existed for the shares underlying these options as of
January 3, 1998. Accordingly, no value in excess of exercise price has been
attributed to these options.
(7) Options to purchase 45,000, 45,000 and 22,500 shares of the common stock of
Thermo Electron granted to Mr. Helm, Dr. Chapman and Mr. Howe,
respectively, are subject to the same terms as described in footnote (2),
except that the repurchase rights of the granting corporation generally do
not lapse until the tenth anniversary of the grant date. In the event of
the employee's death or involuntary termination prior to the tenth
anniversary of the grant date, the repurchase rights of the granting
corporation shall be deemed to have lapsed ratably over a five-year period
commencing with the fifth anniversary of the grant date.
SEVERANCE AGREEMENTS
Thermo Electron has entered into severance agreements with several of its
key employees, including key employees of the Corporation and other majority-
owned subsidiaries. These agreements provide severance benefits if there is a
change of control of Thermo Electron that is not approved by the board of
directors of Thermo Electron and the employee's employment with Thermo Electron
or the majority-owned subsidiary is terminated, for whatever reason, within one
year thereafter. For purposes of the agreements, a change of control exists upon
(i) the acquisition of 50% or more of the outstanding common stock of Thermo
Electron by any person without the prior approval of the board of directors of
Thermo Electron, (ii) the failure of the board of directors of Thermo Electron,
within two years after any contested election of directors or tender or exchange
offer not approved by the board of directors, to be constituted of a majority of
directors holding office prior to such event or (iii) any other event that the
board of directors of Thermo Electron determines constitutes an effective change
of control of Thermo Electron.
In 1983, Thermo Electron entered into a severance agreement with Mr. Smith
which states the benefits to be received as an initial percentage. The initial
percentage was established by the board of directors of Thermo Electron and was
generally based upon Mr. Smith's age and length of service with Thermo Electron
at the time of severance. Benefits under this agreement are to be paid over a
five-year period. The benefit to be paid in the first year is determined by
applying this percentage to Mr. Smith's highest annual total remuneration in any
twelve-month period during the preceding three years. The benefit is reduced 10%
in each of the succeeding four years in which benefits are paid. The initial
percentage to be applied to Mr. Smith is 59.1%.
17
<PAGE>
In 1988, Thermo Electron entered into severance agreements with several
other key employees, including Mr. Helm. Each of the recipients of these
agreements would receive a lump-sum benefit at the time of a qualifying
severance equal to the highest total cash compensation paid to the employee by
Thermo Electron or the majority-owned subsidiary in any 12-month period during
the three years preceding the severance event. A qualifying severance exists if
(i) the employment of the executive officer is terminated for any reason within
one year after a change in control of Thermo Electron or (ii) a group of
directors of Thermo Electron consisting of directors of Thermo Electron on the
date of the severance agreement or, if an election contest or tender or exchange
offer for Thermo Electron's common stock has occurred, the directors of Thermo
Electron immediately prior to such election contest or tender or exchange offer,
and any future directors who are nominated or elected by such directors,
determine that any other termination of the executive officer's employment
should be treated as a qualifying severance. The benefits to be provided are
limited so that the payments would not constitute so-called "excess parachute
payments" under applicable provisions of the Internal Revenue Code of 1986.
Assuming that severance benefits would have been payable under these
agreements as of January 3, 1998, Mr. Smith and Mr. Helm would have received
approximately $345,735 (with respect to the first year in which benefits would
be paid) and $250,500, respectively.
COMMITTEE REPORT ON EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION
All decisions on compensation for the Corporation's executive officers are
made by the human resources committee of the board of directors (the
"Committee"). In reviewing and establishing total cash compensation and stock-
based compensation for executives, the Committee follows guidelines established
by the human resources committee of the board of directors of its parent
company, Thermo Electron. The executive compensation program presently consists
of annual base salary ("salary"), short-term incentives in the form of annual
cash bonuses, and long-term incentives in the form of stock options
(collectively referred to as "total compensation").
The Committee believes that the total compensation of executive officers
should reflect the scope of their responsibilities, the success of the
Corporation, and the contributions of each executive to that success. In
addition, the Committee believes that base salaries should approximate the mid-
point of competitive salaries derived from market surveys and that short-term
and long-term incentive compensation should reflect the performance of the
Corporation and the contributions of each executive.
ESTABLISHING COMPETITIVENESS
External competitiveness is an important element of the Committee's
compensation policy. The competitiveness of the Corporation's total compensation
for its executives is assessed by comparing it to market data provided by
compensation consultants and by participating in annual executive compensation
surveys, primarily "Project 777," an executive compensation survey prepared by
Management Compensation Services, a division of Hewitt Associates. The majority
of firms represented in the Project 777 survey are included in the Standard &
Poor's 500 Index, but do not necessarily correspond to the companies included in
the Corporation's peer group.
Principles of internal equity are also central to the Committee's
compensation policies. Total compensation considered for the Corporation's
officers, whether cash or stock-based incentives, is also evaluated by comparing
it to total compensation of other executives within the Thermo Electron
organization with comparable levels of responsibility for comparably sized
business units.
The process for determining each of these elements for the Corporation's
executive officers is outlined below. For its review of the compensation of
other officers of the Corporation, the Committee follows a substantially similar
process.
18
<PAGE>
BASE SALARY
Base salaries are intended to approximate the mid-point of competitive
salaries for similar organizations of comparable size and complexity to the
Corporation. Executive salaries are adjusted gradually over time and only as
necessary to meet this objective. Increases in base salary may be moderated by
other considerations, such as geographic or regional market data, industry
trends or internal fairness within the Corporation and Thermo Electron. It is
the Committee's intention that over time the base salaries for the chief
executive officer and the other named executive officers will approximate the
mid-point of competitive data. The salary increases in calendar 1997 for the
chief executive officer and the other named executive officers generally reflect
this practice of gradual increases and moderation.
CASH BONUS
The Committee establishes a median potential bonus for each executive by
using the market data on total cash compensation from the same executive
compensation surveys as used to determine salaries. Specifically, the median
potential bonus plus the salary of an executive officer is approximately equal
to the mid-point of competitive total cash compensation for a similar position
and level of responsibility in businesses having comparable sales and complexity
to the Corporation. The actual bonus awarded to an executive officer may range
from zero to three times the median potential bonus. The value within the range
(the bonus multiplier) is determined at the end of each year by the Committee in
its discretion. The Committee exercises its discretion by evaluating each
executive's performance using a methodology developed by its parent company,
Thermo Electron, and applied throughout the Thermo Electron organization. The
methodology incorporates measures of operating returns which are designed to
measure profitability and contributions to shareholder value, and earnings
growth, and are measures of corporate and divisional performance that are
evaluated using graphs developed by Thermo Electron intended to reward
performance that is perceived as above average and to penalize performance that
is perceived as below average. The measures of operating returns used in the
Committee's determinations in fiscal 1997 measured return on net assets, growth
in income, and return on sales, and the Committee's determinations also included
a subjective evaluation of the contributions of each executive that are not
captured by operating measures but are considered important to the creation of
long-term value for the Stockholders. These measures of achievements are not
financial targets that are met, not met or exceeded. The relative weighting of
the operating measures and the subjective evaluation varies among the
executives, depending on their roles and responsibilities within the
organization.
The bonuses for named executive officers approved by the Committee with
respect to fiscal 1997 performance in each instance exceeded the median
potential bonus.
STOCK OPTION PROGRAM
The primary goal of the Corporation and its parent company is to excel in
the creation of long-term value for the Stockholders. The principal incentive
tool used to achieve this goal is the periodic award to key employees of options
to purchase common stock of the Corporation and other Thermo Electron companies.
The Committee and management believe that awards of stock options to
purchase the shares of both the Corporation and other companies within the
Thermo Electron group of companies accomplish many objectives. The grant of
options to key employees encourages equity ownership in the Corporation, and
closely aligns management's interests to the interests of all the Stockholders.
The emphasis on stock options also results in management's compensation being
closely linked to stock performance. In addition, because they are subject to
vesting periods of varying durations and to forfeiture if the employee leaves
the Corporation prematurely, stock options are an incentive for key employees to
remain with the Corporation long-term. The Committee believes stock option
awards in the parent corporation, Thermo Electron, and the other majority-owned
subsidiaries of Thermo Electron, are an important tool in providing incentives
for performance within the entire organization.
In determining awards, the Committee considers for each officer the annual
value of all options to purchase shares of the Corporation and other companies
within the Thermo Electron organization that vest in the next year and compares
the individual's total compensation using this value to competitive data. The
Committee uses a modified Black-Scholes option pricing model to determine the
value of an option award. In addition, the Committee considers the aggregate
amount of net awards to purchase shares of Common Stock granted to all employees
over the last five years to monitor the number of aggregate awards to all
employees. In reviewing the
19
<PAGE>
aggregate number of awards, the Committee considers such factors as the size of
the company, its stage of development, and its growth strategy, as well as the
aggregate awards and option practices of comparably situated companies.
The Committee periodically awards stock options based on its assessment of
the total compensation of each executive, the actual and anticipated
contributions of each executive (which includes a subjective assessment by the
Committee of the value of the executive's future potential within the
organization), as well as the value of previously awarded options as described
above, in determining option awards. The option awards made to the named
executive officers in 1997 with respect to the common stock of certain majority-
owned subsidiaries of the Corporation were determined by the human resources
committee of the board of directors of the granting company using a similar
analysis. In addition, the options awarded in 1997 to the named executive
officers with respect to the common stock of Thermo Electron were made by the
Thermo Electron human resources committee under a program that awards options to
certain eligible employees annually based on the number of shares of the common
stock of Thermo Electron held by the employee, as an incentive to buy and hold
Thermo Electron shares.
STOCK OWNERSHIP AND RETENTION POLICIES
The Committee established a stock holding policy for executive officers of
the Corporation in 1996 that required executive officers to own a multiple of
their compensation in shares of the Corporation's Common Stock. For the chief
executive officer, the multiple was one times his base salary and reference
bonus for the calendar year. For all other officers, the multiple was one times
the officer's base salary. The Committee deemed it appropriate to permit
officers to achieve these ownership levels over a three-year period. The policy
was amended in 1998 to apply only to the chief executive officer.
In order to assist officers in complying with the policy, the Committee
also adopted in 1996 a stock holding assistance plan under which the Corporation
was authorized to make interest-free loans to officers to enable them to
purchase shares of the Common Stock in the open market. The loans are required
to be repaid upon the earlier of demand or the fifth anniversary of the date of
the loan, unless otherwise authorized by the Committee. No loans were
outstanding under this plan in 1997. This plan was also amended in 1998 to
apply only to the chief executive officer.
The Committee also has adopted a policy requiring its executive officers to
hold shares of the Corporation's Common Stock acquired upon the exercise of
stock options granted by the Corporation. Under this policy, executive officers
are required to hold one-half of their net option exercises over a period of
five years. The net option exercise is determined by calculating the number of
shares acquired upon exercise of a stock option, after deducting the number of
shares that could have been traded to exercise the option and the number of
shares that could have been surrendered to satisfy tax withholding obligations
attributable to the exercise of the options.
Similar stock holding policies and stock holding assistance plans have been
adopted by each of the Corporation's publicly traded, majority-owned
subsidiaries. Certain executive officers of the Corporation who are chief
executive officers of these subsidiaries are required to comply with these stock
holding policies in lieu of the Corporation's stock holding policy. See
"Relationship with Affiliates Stock Holding Assistance Plans."
POLICY ON DEDUCTIBILITY OF COMPENSATION
The Committee has also considered the application of Section 162(m) of the
Internal Revenue Code to the Corporation's compensation practices. Section
162(m) limits the tax deduction available to public companies for annual
compensation paid to senior executives in excess of $1 million unless the
compensation qualifies as "performance based" or is otherwise exempt under
Section 162(m). The annual compensation paid to individual executives does not
approach the $1 million threshold, and it is believed that the stock incentive
plans of the Corporation qualify as "performance based." Therefore, the
Committee does not believe any further action is necessary in order to comply
with Section 162(m). From time to time, the Committee will reexamine the
Corporation's compensation practices and the effect of Section 162(m).
20
<PAGE>
1997 CEO COMPENSATION
Cash compensation for Mr. Arvin H. Smith, who was the Corporation's chief
executive officer during fiscal 1997, was reviewed by both the Committee and the
human resources committee of the board of directors of Thermo Electron, due to
his responsibilities as both the Corporation's chief executive officer and as an
executive vice president of Thermo Electron, the Corporation's parent company.
Each committee evaluates Mr. Smith's performance and proposed compensation using
a process similar to that used for the other executive officers of the
Corporation. At the Thermo Electron level, Mr. Smith was evaluated on his
performance related to the Corporation as well as other operating units of
Thermo Electron for which he was responsible, weighted in accordance with the
amount of time and effort devoted to each operation. The Corporation's Committee
then reviewed the analysis and determinations of the Thermo Electron committee,
made an independent assessment of Mr. Smith's performance as it relates to the
Corporation using criteria similar to that used for the other executive officers
of the Corporation, and then agreed to an appropriate allocation of Mr. Smith's
compensation to be paid by the Corporation.
In December 1997, the Committee conducted its review of Mr. Smith's
proposed salary for 1998 and bonus for 1997 performance. The Committee
concurred in the bonus recommendation made by the Thermo Electron committee and
agreed to an allocation of 50% of Mr. Smith's total cash compensation for 1997
to the Corporation, based on his relative responsibilities at the Corporation
and Thermo Electron.
Awards to Mr. Smith of options to purchase shares of the Corporation's
Common Stock are reviewed and determined periodically by the Committee using
criteria similar to those used for the other executive officers of the
Corporation. No awards to purchase shares of the Corporation's Common Stock
were made to Mr. Smith in fiscal 1997. In 1997, Mr. Smith was awarded options
to purchase shares of the common stock of the following majority-owned
subsidiaries of the Corporation: Metrika Systems Corporation and Thermo Vision
Corporation. These option awards were granted in connection with Mr. Smith's
position as a director of these companies by the human resources committee of
the applicable majority-owned subsidiary and were determined in a manner
consistent with awards to other officers, as described above under the caption
"Stock Option Program."
Col. Frank Borman (Chairman)
Mr. Polyvios C. Vintiadis
21
<PAGE>
COMPARATIVE PERFORMANCE GRAPH
The Securities and Exchange Commission requires that the Corporation
include in this proxy statement a line-graph presentation comparing cumulative,
five-year shareholder returns for the Corporation's Common Stock with a broad-
based market index and either a nationally recognized industry standard or an
index of peer companies selected by the Corporation. The Corporation has
compared its performance with the American Stock Exchange Market Value Index and
a peer group of instrument companies comprised of Beckman Instruments Inc.,
Dionex Inc., Emerson Electric Corp., Perkin-Elmer Corp. and Varian Associates
Inc. (the "Peer Group") as of the last trading day of the Corporation's fiscal
year.
COMPARISON OF TOTAL RETURN AMONG THERMO INSTRUMENT SYSTEMS INC.,
THE AMERICAN STOCK EXCHANGE MARKET VALUE INDEX, AND THE
CORPORATION'S PEER GROUP FROM
DECEMBER 31, 1992 TO JANUARY 2, 1998
[GRAPH APPEARS HERE]
<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------
12/31/92 12/31/93 12/30/94 12/29/95 12/27/96 1/2/98
- ---------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
THI 100 151 138 219 267 345
- ---------------------------------------------------------------------------------------
AMEX 100 120 109 137 146 177
- ---------------------------------------------------------------------------------------
PEER GROUP 100 113 117 159 197 229
- ---------------------------------------------------------------------------------------
</TABLE>
The total return for the Corporation's Common Stock (THI), the American
Stock Exchange Market Value Index (AMEX), and the Peer Group assumes the
reinvestment of dividends, although dividends have not been declared on the
Corporation's Common Stock. The American Stock Exchange Market Value Index
tracks the aggregate performance of equity securities of companies listed on the
American Stock Exchange. The Corporation's Common Stock is traded on the
American Stock Exchange under the ticker symbol "THI."
RELATIONSHIP WITH AFFILIATES
Thermo Electron has adopted a strategy of selling a minority interest in
subsidiary companies to outside investors as an important tool in its future
development. As part of this strategy, Thermo Electron and certain of its
subsidiaries have created several privately and publicly held subsidiaries. The
Corporation has created Metrika Systems Corporation, ONIX Systems Inc., Thermo
BioAnalysis Corporation, Thermo Optek Corporation,
22
<PAGE>
ThermoQuest Corporation, ThermoSpectra Corporation and Thermo Vision
Corporation. From time to time, Thermo Electron and its subsidiaries will create
other majority-owned subsidiaries as part of its spinout strategy. (The
Corporation and such other majority-owned Thermo Electron subsidiaries are
hereinafter referred to as the "Thermo Subsidiaries.")
Thermo Electron and each of the Thermo Subsidiaries recognize that the
benefits and support that derive from their affiliation are essential elements
of their individual performance. Accordingly, Thermo Electron and each of the
Thermo Subsidiaries have, including the Corporation, adopted the Thermo Electron
Corporate Charter (the "Charter") to define the relationships and delineate the
nature of such cooperation among themselves. The purpose of the Charter is to
ensure that (1) all of the companies and their stockholders are treated
consistently and fairly, (2) the scope and nature of the cooperation among the
companies, and each company's responsibilities, are adequately defined, (3) each
company has access to the combined resources and financial, managerial and
technological strengths of the others, and (4) Thermo Electron and the Thermo
Subsidiaries, in the aggregate, are able to obtain the most favorable terms from
outside parties.
To achieve these ends, the Charter identifies the general principles to be
followed by the companies, addresses the role and responsibilities of the
management of each company, provides for the sharing of group resources by the
companies and provides for centralized administrative, banking and credit
services to be performed by Thermo Electron. The services provided by Thermo
Electron include collecting and managing cash generated by members, coordinating
the access of Thermo Electron and the Thermo Subsidiaries (the "Thermo Group")
to external financing sources, ensuring compliance with external financial
covenants and internal financial policies, assisting in the formulation of long-
range planning and providing other banking and credit services. Pursuant to the
Charter, Thermo Electron may also provide guarantees of debt or other
obligations of the Thermo Subsidiaries or may obtain external financing at the
parent level for the benefit of the Thermo Subsidiaries. In certain instances,
the Thermo Subsidiaries may provide credit support to, or on behalf of, the
consolidated entity or may obtain financing directly from external financing
sources. Under the Charter, Thermo Electron is responsible for determining that
the Thermo Group remains in compliance with all covenants imposed by external
financing sources, including covenants related to borrowings of Thermo Electron
or other members of the Thermo Group, and for apportioning such constraints
within the Thermo Group. In addition, Thermo Electron establishes certain
internal policies and procedures applicable to members of the Thermo Group. The
cost of the services provided by Thermo Electron to the Thermo Subsidiaries is
covered under existing corporate services agreements between Thermo Electron and
each of the Thermo Subsidiaries.
The Charter presently provides that it shall continue in effect so long as
Thermo Electron and at least one Thermo Subsidiary participate. The Charter may
be amended at any time by agreement of the participants. Any Thermo Subsidiary,
including the Corporation, can withdraw from participation in the Charter upon
30 days' prior notice. In addition, Thermo Electron may terminate a subsidiary's
participation in the Charter in the event the subsidiary ceases to be controlled
by Thermo Electron or ceases to comply with the Charter or the policies and
procedures applicable to the Thermo Group. A withdrawal from the Charter
automatically terminates the corporate services agreement and tax allocation
agreement (if any) in effect between the withdrawing company and Thermo
Electron. The withdrawal from participation does not terminate outstanding
commitments to third parties made by the withdrawing company, or by Thermo
Electron or other members of the Thermo Group, prior to the withdrawal. In
addition, a withdrawing company is required to continue to comply with all
policies and procedures applicable to the Thermo Group and to provide certain
administrative functions mandated by Thermo Electron so long as the withdrawing
company is controlled by or affiliated with Thermo Electron.
As provided in the Charter, the Corporation and Thermo Electron have
entered into a Corporate Services Agreement (the "Services Agreement") under
which Thermo Electron's corporate staff provides certain administrative
services, including certain legal advice and services, risk management, employee
benefit administration, tax advice and preparation of tax returns, centralized
cash management and financial and other services to the Corporation. The
Corporation was assessed an annual fee equal to 1.0% of the Corporation's
revenues for these services in fiscal 1996 and 1997. The annual fee has been
reduced to 0.8% of the Corporation's total revenues for fiscal 1998. The fee is
reviewed annually and may be changed by mutual agreement of the Corporation and
Thermo Electron. During fiscal 1997, Thermo Electron assessed the Corporation
$15.9 million in fees under the Services Agreement. Management believes that the
charges under the Services Agreement are reasonable and that the terms of the
Services Agreement are fair to the Corporation. For items such as employee
23
<PAGE>
benefit plans, insurance coverage and other identifiable costs, Thermo Electron
charges the Corporation based on charges attributable to the Corporation. The
Services Agreement automatically renews for successive one-year terms, unless
canceled by the Corporation upon 30 days' prior notice. In addition, the
Services Agreement terminates automatically in the event the Corporation ceases
to be a member of the Thermo Group or ceases to be a participant in the Charter.
In the event of a termination of the Services Agreement, the Corporation will be
required to pay a termination fee equal to the fee that was paid by the
Corporation for services under the Services Agreement for the nine-month period
prior to termination. Following termination, Thermo Electron may provide certain
administrative services on an as-requested basis by the Corporation or as
required in order to meet the Corporation's obligations under Thermo Electron's
policies and procedures. Thermo Electron will charge the Corporation a fee equal
to the market rate for comparable services if such services are provided to the
Corporation following termination.
The Corporation has entered into a Tax Allocation Agreement with Thermo
Electron which outlines the terms under which the Corporation will be included
in Thermo Electron's consolidated Federal and state income tax returns. Under
current law, the Corporation will be included in such tax returns so long as
Thermo Electron owns at least 80% of the outstanding common stock of the
Corporation. In years in which the Corporation has taxable income, it will pay
to Thermo Electron amounts comparable to the taxes the Corporation would have
paid if it had filed its own separate company tax returns. If Thermo Electron's
equity ownership of the Corporation were to drop below 80%, the Company would
file its own tax returns. In 1997, the Corporation paid Thermo Electron
$29,100,000 under the Tax Allocation Agreement.
From time to time the Corporation may transact business with other
companies in the Thermo Group.
The Corporation purchases and sells products and/or services in the
ordinary course of business to Thermo Electron and Thermo Electron's other
subsidiaries. In 1997, the Corporation sold a total of $1,720,000 of products
to Thermo Electron and its other subsidiaries and purchased a total of
$1,665,000 of products and/or services from such companies.
In 1997, the Corporation's majority-owned subsidiary Metrika Systems
Corporation ("Metrika") paid a 10% commission totaling $83,000 to Thermo Sentron
Inc., ("Thermo Sentron"), a majority-owned subsidiary of Thermedics Inc., which
is in turn a majority-owned subsidiary of Thermo Electron, for assisting in the
sale by Metrika of its products in Australia.
A majority-owned subsidiary of the Corporation, Thermo Optek Corporation
("Thermo Optek"), leases office and manufacturing space to Nicolet Biomedical
Inc. ("Nicolet Biomedical"), a wholly owned subsidiary of Thermo Electron,
pursuant to an arrangement whereby Thermo Optek charges Nicolet Biomedical its
allocated share of the occupancy expenses of Thermo Optek's principal Wisconsin
facility, based on the space Nicolet Biomedical utilizes. Thermo Optek recorded
operating lease income of $698,000 in 1997 from Nicolet Biomedical. This lease
is effective until December 31, 1998, but may be terminated by Nicolet
Biomedical upon 30 days' prior notice to Thermo Optek.
A majority-owned subsidiary of the Corporation, ThermoSpectra Corporation
("ThermoSpectra") has an arrangement with ThermoTrex Corporation ("ThermoTrex"),
a publicly traded, majority-owned subsidiary of Thermo Electron, whereby
ThermoTrex provides certain research and development services to ThermoSpectra,
and ThermoSpectra purchases flat screen x-ray sensitive detectors pursuant to
purchase orders. In 1997, ThermoSpectra paid ThermoTrex $136,000 for such
products and services.
As of January 3, 1998, the Corporation had outstanding $140,000,000 of
indebtedness to Thermo Electron, represented by a 3 3/4% Senior Convertible
Note due 2000. As of January 3, 1998, each of Thermo Optek and ThermoQuest
Corporation ("ThermoQuest"), also a majority-owned subsidiary of the
Corporation, had $10,000,000 of outstanding indebtedness to Thermo Electron
pursuant to Thermo Optek's 5% Convertible Subordinated Debentures due 2000 and
ThermoQuest's 5% Convertible Subordinated Debentures due 2000.
In connection with the 1997 acquisition of Spectronic Instruments Inc. and
VG Systems Limited from the Corporation, Thermo Optek borrowed $40,000,000 from
Thermo Electron pursuant to a promissory note due August
24
<PAGE>
1998. This note bears interest at the 90-day Commercial Paper Composite Rate
plus 25 basis points, set at the beginning of each quarter. The interest rate
for the note outstanding at January 3, 1998 was 5.76%.
In March 1997 the Corporation borrowed $210,000,000 from Thermo Electron to
fund its acquisition of the shares of Life Sciences International plc ("Life
Sciences") pursuant to the Corporation's tender offer for all of the outstanding
shares of Life Sciences. This obligation is evidenced by a promissory note due
March 26, 1999 and bearing interest at a rate equal to the 90-day Commercial
Paper Composite Rate plus 25 basis points. In June 1997, to finance the
repayment of Life Sciences' debt, the Corporation borrowed an additional $115
million from Thermo Electron, which was repaid in September 1997.
On November 6, 1997, Thermo Power Corporation, a majority-owned subsidiary
of Thermo Electron ("Thermo Power"), acquired Peek plc. The Corporation's ONIX
Systems Inc. subsidiary ("ONIX") acquired the Peek Measurement Business from
Thermo Power for approximately $19.1 million, effective November 1997. The
purchase price represents the sum of (i) the net tangible book value of the Peek
Measurement Business as of the date of the acquisition by Thermo Power, plus
(ii) the total goodwill associated with Thermo Power's acquisition of Peek plc
multiplied by the ratio of the total fiscal 1997 revenues of the Peek
Measurement Business to the total fiscal 1997 revenues of Peek plc, plus (iii)
$1.0 million, which represents an estimate of the amount of tax that will be
incurred by Thermo Power as a result of the transfer of the Peek Measurement
Business to ONIX. In addition, ONIX paid $256,000 in interest, representing
interest on the purchase price, from November 6, 1997 through January 28, 1998
at an interest rate equal to the 90-day Commercial Paper Composite Rate plus 25
basis points, set at the beginning of each quarter.
Commencing January 1998, ONIX leases approximately 24,000 square feet of a
60,000-square-foot facility in Winchester, England on a month-to-month basis
from Thermo Power. ONIX pays Thermo Power rent in an amount that is
approximately equal to the pro rata share of Thermo Power's occupancy costs
including utilities and taxes, which payments in 1998 are estimated to be
approximately 139,000 British pounds sterling (approximately $229,000) in the
aggregate.
The Corporation, along with certain other Thermo Subsidiaries, participates
in a notional pool arrangement with Barclays Bank, which includes a $150 million
credit facility. Only European-based Thermo Subsidiaries participate in this
arrangement. Under this arrangement the Bank notionally combines the positive
and negative cash balances held by the participants to calculate the net
interest yield/expense for the group. The benefit derived from this arrangement
is then allocated based on balances attributable to the respective participants.
Thermo Electron guarantees all of the obligations of each participant in this
arrangement. In addition, funds on deposit under this arrangement provide
credit support for overdraft obligations of other participants. As of January
3, 1998, the Corporation had a negative cash balance of approximately
$1,520,000, based on an exchange rate of $1.65/(Pounds)1.00 as of January 3,
1998. For 1997, the average annual interest rate earned on GBP deposits by
participants in this credit arrangement was approximately 6.5% and the average
annual interest rate paid on overdrafts was approximately 7.2%.
The Corporation, along with certain other Thermo Subsidiaries, also
participates in a notional pool arrangement with ABN AMRO, which includes a $50
million credit facility. Only European-based Thermo Subsidiaries participate in
this arrangement. Under this arrangement the Bank notionally combines the
positive and negative cash balances held by the participants to calculate the
net interest yield/expense for the group. The benefit derived from this
arrangement is then allocated based on balances attributable to the respective
participants. Thermo Electron guarantees all of the obligations of each
participant in this arrangement. In addition, funds on deposit under this
arrangement provide credit support for overdraft obligations of other
participants. As of January 3, 1998, the Corporation had a negative cash
balance of approximately $4,622,000, based on an exchange rate of $0.495/NLG1.00
as of January 3, 1998. For 1997, the average annual interest rate earned on NLG
deposits by participants in this credit arrangement was approximately 4.8% and
the average annual interest rate paid on NLG overdrafts was approximately 4.8%.
In connection with the 1996 acquisition of Kevex Instruments and Kevex X-
ray, ThermoSpectra borrowed $15,000,000 from Thermo Electron pursuant to a
promissory note due August 1998. In connection with the acquisition of Park
Scientific Instruments Corporation in March 1997, ThermoSpectra borrowed
$10,000,000 from Thermo Electron pursuant to a promissory note due March 1999.
In connection with the acquisition of NESLAB Instruments, Inc. and its related
sales and service entity, NESLAB Instruments Europa BV in the Netherlands, from
25
<PAGE>
the Corporation in July 1997, ThermoSpectra borrowed $45,000,000 from Thermo
Electron pursuant to a promissory note due July 1999. To partially finance the
acquisition of Sierra Research and Technology Inc. in July 1997, ThermoSpectra
borrowed $5,000,000 from Thermo Electron pursuant to a promissory note due July
1999. These notes bear interest at the 90-day Commercial Paper Composite Rate
plus 25 basis points, set at the beginning of each quarter. The interest rate
for the notes outstanding in 1997 was 5.76%.
At January 3, 1998, the Corporation owed Thermo Electron and its other
subsidiaries an aggregate of $2,910,000 for amounts due under the Corporate
Services Agreement and related administrative charges, the Tax Allocation
Agreement, for other products and services, and for miscellaneous items,
excluding loans described above, net of amounts owed to the Corporation by
Thermo Electron and its other subsidiaries for products, services and other
miscellaneous items. The largest amount of net indebtedness owed by the
Corporation to Thermo Electron and its other subsidiaries since December 29,
1996 was $20,550,000. These amounts do not bear interest and are expected to be
paid in the normal course of business
In October 1997, Crescent International Holdings Limited purchased from
ONIX 16,666 shares of its common stock in a private placement at a price per
share of $14.25, the same price per share paid by unaffiliated buyers. Crescent
International Holdings Limited is indirectly controlled by Suliman S. Olayan,
the father of Ms. Hutham S. Olayan, a director of ONIX and of Thermo Electron.
Ms. Olayan disclaims beneficial ownership of the shares owned by Crescent
International Holdings Limited.
Thermo Electron owned approximately 83.6% of the Corporation's outstanding
Common Stock on January 3, 1998. Thermo Electron intends for the foreseeable
future to maintain at least 80% ownership of the Corporation. This may require
the purchase by Thermo Electron of additional shares of the Corporation's Common
Stock from time to time as the number of outstanding shares issued by the
Corporation increases. These purchases may be made either in the open market or
directly from the Corporation or through conversion of convertible debentures
owned by Thermo Electron. In January 1996, the Corporation adopted a plan for
the sale of its shares to Thermo Electron at the request of Thermo Electron to
allow Thermo Electron to maintain 80% ownership of the Corporation. The sale
of shares pursuant to such plan would be made at fair market value and would be
subject to approval of a committee of the board of directors formed for that
purpose.
As of January 3, 1998, approximately $284 million of the Corporation's cash
equivalents were invested in a repurchase agreement with Thermo Electron. Under
this agreement, the Corporation in effect lends excess cash to Thermo Electron,
which Thermo Electron collateralizes with investments principally consisting of
corporate notes, U.S. government agency securities, money market funds,
commercial paper and other marketable securities, in the amount of at least 103%
of such obligation. The Corporation's funds subject to the repurchase agreement
are readily convertible into cash by the Corporation. The repurchase agreement
earns a rate based on the 90-day Commercial Paper Composite Rate plus 25 basis
points, set at the beginning of each quarter.
STOCK HOLDING ASSISTANCE PLAN
In 1996, the Corporation adopted a stock holding policy which requires its
executive officers to acquire and hold a minimum number of shares of Common
Stock. In order to assist the executive officers in complying with the policy,
the Corporation also adopted a stock holding assistance plan under which it may
make interest-free loans to certain key employees, including its executive
officers, to enable such employees to purchase Common Stock in the open market.
This policy and plan were amended in 1998 to apply only to the chief executive
officer of the Corporation in the future. No such loans are currently
outstanding under the plan.
Each of the Corporation's publicly traded, majority-owned subsidiaries have
adopted similar stock holding policies and stock holding assistance plans which
were applicable to their executive officers prior to their amendment in 1998 to
make them applicable only to their chief executive officers. Certain executive
officers of the
26
<PAGE>
Corporation are also the chief executive officers of these subsidiaries and are
required to comply with the subsidiary's stock holding policies. Mr. Earl R.
Lewis, the Corporation's president and chief operating officer, was also the
chief executive officer of Thermo Optek until January 4, 1998. Dr. Richard W.K.
Chapman, a vice president of the Corporation, is also the chief executive
officer of ThermoQuest and was chairman of the board of Thermo BioAnalysis until
June 26, 1997. Mr. Barry S. Howe, a vice president of the Corporation, was also
the chief executive officer of Thermo BioAnalysis until March 11, 1998 and is
currently the chief executive officer of ThermoSpectra. In 1996, Mr. Lewis
received a loan in the principal amount of $194,029.50 under the Thermo Optek
stock holding assistance plan to purchase 15,000 shares of the common stock of
Thermo Optek, of which amount $155,223.60 is still outstanding. Dr. Chapman
received loans in 1996 in the principal amounts of $210,653.50 and $131,176.30
under the stock holding assistance plans of ThermoQuest and Thermo BioAnalysis,
respectively, to purchase 15,000 shares of the common stock of ThermoQuest and
10,000 shares of the common stock of Thermo BioAnalysis, of which amounts
$168,522.80 and $131,176.30, respectively, are still outstanding. In 1996, Mr.
Howe received loans in the principal amount of $164,375.52 under the stock
holding assistance plan of Thermo BioAnalysis to purchase 12,000 shares of
Thermo BioAnalysis, of which amount $131,500.42 is still outstanding. In 1998,
Mr. Howe received a loan in the principal amount of $141,991.78 to purchase
15,000 shares of Thermo BioAnalysis, of which the entire amount is still
outstanding. Each of these loans is repayable upon the earlier of demand or the
fifth anniversary of the date of the loan, unless otherwise authorized by the
human resources committee of the board of directors of the applicable company.
APPOINTMENT OF INDEPENDENT PUBLIC ACCOUNTANTS
The board of directors has appointed Arthur Andersen LLP as independent
public accountants for fiscal 1998. Arthur Andersen LLP has acted as independent
public accountants for the Corporation since 1986. Representatives of that firm
are expected to be present at the Meeting, will have the opportunity to make a
statement if they desire to do so and will be available to respond to questions.
The board of directors has established an audit committee, presently consisting
of three outside directors, the purpose of which is to review the scope and
results of the audit.
OTHER ACTION
Management is not aware at this time of any other matters that will be
presented for action at the Meeting. Should any such matters be presented, the
proxies grant power to the proxy holders to vote shares represented by the
proxies in the discretion of such proxy holders.
STOCKHOLDER PROPOSALS
Proposals of Stockholders intended to be presented at the 1999 Annual
Meeting of the Stockholders of the Corporation must be received by the
Corporation for inclusion in the proxy statement and form of proxy relating to
that meeting no later than December 29, 1998.
SOLICITATION STATEMENT
The cost of this solicitation of proxies will be borne by the Corporation.
Solicitation will be made primarily by mail, but regular employees of the
Corporation may solicit proxies personally or by telephone, facsimile
transmission or telegram. Brokers, nominees, custodians and fiduciaries are
requested to forward solicitation materials to obtain voting instructions from
beneficial owners of stock registered in their names, and the Corporation will
reimburse such parties for their reasonable charges and expenses in connection
therewith.
Hurst, Texas
April 23, 1998
27
<PAGE>
FORM OF PROXY
THERMO INSTRUMENT SYSTEMS INC.
PROXY FOR ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 1, 1998
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS.
The undersigned hereby appoints John N. Hatsopoulos, Melissa F.
Riordan and Arvin H. Smith, or any one of them in the absence of the others, as
attorneys and proxies of the undersigned, with full power of substitution, for
and in the name of the undersigned, to represent the undersigned at the Annual
Meeting of the Stockholders of Thermo Instrument Systems Inc., a Delaware
corporation (the "Company"), to be held on Monday, June 1, 1998, at 9:00 a.m. at
The Hyatt Regency Scottsdale Resort at Gainey Ranch, Scottsdale, Arizona, and at
any adjournment or postponement thereof, and to vote all shares of common stock
of the Company standing in the name of the undersigned on April 3, 1998, with
all of the powers the undersigned would possess if personally present at such
meeting:
(IMPORTANT - TO BE SIGNED AND DATED ON THE REVERSE SIDE.)
<PAGE>
Please mark your
[ X ] votes as in this
example.
1. ELECTION OF DIRECTORS OF THE COMPANY (see reverse).
FOR [ ] WITHHELD [ ]
FOR all nominees listed at right, except authority to vote withheld for the
following nominees (if any): ______________________________________
NOMINEES: Frank Borman, George N. Hatsopoulos, John N. Hatsopoulos, Earl R.
Lewis, Arvin H. Smith and Polyvios C. Vintiadis.
2. In their discretion on such other matters as may properly come before the
Meeting.
THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED "FOR" THE PROPOSALS SET FORTH
ABOVE IF NO INSTRUCTION TO THE CONTRARY IS INDICATED OR IF NO INSTRUCTION IS
GIVEN.
Copies of the Notice of Meeting and of the Proxy Statement have been received
by the undersigned.
PLEASE DATE, SIGN AND PROMPTLY RETURN THIS PROXY IN THE ENCLOSED ENVELOPE.
SIGNATURE(S)_______________________________________ DATE_________________
NOTE: This proxy should be dated, signed by the shareholder(s) exactly as his
or her name appears hereon, and returned promptly in the enclosed
envelope. Persons signing in a fiduciary capacity should so indicate. If
shares are held by joint tenants or as community property, both should
sign.
